AzTrials
AzTrials

DefibrillatorsNCT03521050

LUKS-Leads Registry on Long-term Performance of ICD Leads

An observational study of Defibrillators and Electrical Shock, run by Luzerner Kantonsspital at 1 site in Switzerland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

All patients having an implantable cardiac defibrillator (ICD) implanted and having follow-up at the Cantonal Hospital Lucerne (LUKS), the investigator center, are included in this retrospective ICD lead registry from 2006 onwards. Data is collected prospectively from december 2016 onwards. Read more about this study

Who is it for?
Any age
Conditions the study is for
Defibrillators, Electrical Shock
What is being tested?
defibrillator lead
Type of treatment
Medical device
How many people
1,000 participants
Where
1 siteSwitzerland
Study dates
Dec 2016to Dec 2026
How long will I take part?
10 Years
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients with a clinical indication for an ICD

Who may be able to join

  • all patients being implanted with a Defibrillator lead from 2006 onwards

Who cannot join

  • documented refusal of data collection for scientific purposes

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Richard Kobza, MD contact

+41412055144

richard.kobza@luks.ch

Brigitta Mehmann, PHD contact

+41412052455

brigitta.mehmann@luks.ch

Switzerland1 site, 1 recruiting
  • Luzerner Heart Centre

    Lucerne, 6000

    Richard Kobza, MD, +41412055144, richard.kobza@luks.ch

    Recruiting

Other trials in Switzerland

About this study

All patients having an implantable cardiac defibrillator (ICD) implanted and having follow-up at the Cantonal Hospital Lucerne (LUKS), the investigator center, are included in this retrospective ICD lead registry from 2006 onwards. Data is collected prospectively from december 2016 onwards. After certain ICD-leads tended to fail early the investigators aimed for a registry monitoring our patient population with defibrillator leads and evaluating their long-term performance.

Read the detailed description

All patients having an ICD implanted and having follow-up at the investigators center are included in this retrospective ICD lead registry from 2006 onwards. Data is collected prospectively from december 2016 onwards. After certain ICD-leads tended to fail early the investigators aimed for a registry monitoring our patient population with defibrillator leads and evaluating their long-term performance.

The following parameters will be measured during regular clinical controls: electronic impedances, threshold values, sensing values, battery performance, inadequate/adequate shock release und software problems

Being tested
defibrillator lead

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • defibrillator leadDevice

    observation of long-term performance of defibrillator leads

Study groups in NCT03521050
Study groupRoleWhat they receive
implanted defibrillator leadpatients having an ICD implanted and having follow-up at the investigators center
Receives: Device: defibrillator lead

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. performance of lead impedance

    electronic impedances in Ω

    Measured: regular clinical controls within 10 years

  2. performance of lead threshold

    threshold values in V

    Measured: during regular clinical controls within 10 years

  3. performance of lead sensing

    sensing values in millivolt (mV)

    Measured: during regular clinical controls within 10 years

  4. lead parameters

    battery performance in %

    Measured: during regular clinical controls within 10 years

  5. performance of defibrillator

    inadequate/adequate shock release in numbers

    Measured: during regular clinical controls within 10 years

  6. control system of defibrillator

    software problems in numbers and descriptive

    Measured: during regular clinical controls within 10 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 May 2018
  2. Study startDec 2016
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
1,000 participants (estimated)
Target duration
10 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT03521050
Sponsor's protocol ID
2016-02002
Other IDs
2016
Status last verified
Sep 2020
First submitted
27 Nov 2017
Last updated
4 Sep 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Defibrillators and Electrical Shock, run by Luzerner Kantonsspital at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Richard Kobza, MD (+41412055144, richard.kobza@luks.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

performance of lead impedance (time frame: regular clinical controls within 10 years). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in